GEF-BMEDIUM SIGNALMANAGEMENT10-K

GEF-B is changing its fiscal year end from October 31 to September 30, creating an 11-month transition period for fiscal 2025.

The fiscal year change represents a significant operational shift that will affect financial reporting comparability and investor analysis going forward. The transition creates a shorter reporting period that may complicate year-over-year comparisons and could indicate strategic realignment with industry or seasonal business patterns.

Comparing 2024-12-23 vs 2023-12-18View on EDGAR →
FINANCIAL ANALYSIS

GEF-B's financial performance shows mixed results with operating income declining 23.3% to $464.6M and net income falling 25.2% to $268.8M, while SG&A expenses increased 15.6%. Interest expense dropped dramatically from $76.0M to $2.2M, suggesting significant debt restructuring or refinancing benefits. The balance sheet expanded with total debt increasing 23% to $2.7B and total assets growing 11.5% to $6.6B, though operating cash flow declined meaningfully to $356.0M from $649.5M, indicating potential working capital or operational efficiency challenges.

FINANCIAL STATEMENT CHANGES
Interest Expense
P&L
-97.1%
$76.0M→$2.2M

Interest expense declined — debt repayment or refinancing at lower rates improving earnings quality.

Operating Cash Flow
Cash Flow
-45.2%
$649.5M→$356.0M

Operating cash flow fell 45.2% — earnings quality concerns; investigate working capital changes and non-cash items.

Net Income
P&L
-25.2%
$359.2M→$268.8M

Net income declined 25.2% — review whether driven by operations, interest costs, or non-recurring items.

Operating Income
P&L
-23.3%
$605.5M→$464.6M

Operating profitability softening — costs rising faster than revenue, watch for margin recovery plan.

Total Debt
Balance Sheet
+23%
$2.2B→$2.7B

Debt rose 23% — additional borrowing for investment or operations; monitor coverage ratios.

SG&A Expense
P&L
+15.6%
$549.1M→$634.5M

SG&A increased modestly — likely reflects growth-related hiring or sales expansion investment.

Accounts Receivable
Balance Sheet
+13.3%
$659.4M→$746.9M

Receivables grew 13.3% — monitor days sales outstanding for collection efficiency.

Current Assets
Balance Sheet
+13.2%
$1.4B→$1.5B

Current assets grew 13.2% — improving short-term liquidity or inventory/receivables build.

Total Assets
Balance Sheet
+11.5%
$6.0B→$6.6B

Asset base grew 11.5% — expansion through organic growth, acquisitions, or capital deployment.

LANGUAGE CHANGES
NEW — 2024-12-23
PRIOR — 2023-12-18
ADDED
The 2025 Proxy Statement will be filed within 120 days of October 31, 2024.
Cybersecurity 16 2 Properties 18 3 Legal Proceedings 18 4 Mine Safety Disclosures 19 Part II 5 Market for the Registrant s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 19 7 Management s Discussion and Analysis of Financial Condition and Results of Operations 21 7A.
Through the end of our 2024 fiscal year, our fiscal year began on November 1 and ended on October 31 of the following year.
However, we are changing our fiscal year end, effective for the 2025 fiscal year.
Our 2025 fiscal year will begin on November 1, 2024 and end on September 30, 2025, and accordingly, will consist of eleven months.
+7 more — sign up free →
REMOVED
The 2024 Proxy Statement will be filed within 120 days of October 31, 2023.
Unresolved Staff Comments 18 2 Properties 19 3 Legal Proceedings 19 4 Mine Safety Disclosures 20 Part II 5 Market for the Registrant s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 20 7 Management s Discussion and Analysis of Financial Condition and Results of Operations 22 7A.
Our fiscal year begins on November 1 and ends on October 31 of the following year.
See subsection (g) of this Item 1, Recent Events - Proposed Acquisition of Ipackchem, for information concerning our planned acquisition of Ipackchem Group SAS ( Ipackchem ), a global market leader in the production of high performance plastic packaging, including premium barrier and non-barrier jerrycans and small plastic containers, which was announced on October 31, 2023.
Unless expressly identified herein, information in this Form 10-K does not reflect our proposed acquisition of Ipackchem or its business operations, products, services or financial results.
+7 more — sign up free →
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →